Skip to main content
Erschienen in: Reactions Weekly 1/2010

01.07.2010 | Case report

Imatinib/interferon-α

Acute lymphoblastic leukaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Wang L, Zhu K, Zha X, Chen S, Yang L, Chen S, Li Y.Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. Journal of Hematology and Oncology 3: Jan 2010. Available from: URL: http://dx.doi.org/10.1186/1756-8722-3-14 - China Wang L, Zhu K, Zha X, Chen S, Yang L, Chen S, Li Y.Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. Journal of Hematology and Oncology 3: Jan 2010. Available from: URL: http://​dx.​doi.​org/​10.​1186/​1756-8722-3-14 - China
Metadaten
Titel
Imatinib/interferon-α
Acute lymphoblastic leukaemia: case report
Publikationsdatum
01.07.2010
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2010
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201013110-00098

Weitere Artikel der Ausgabe 1/2010

Reactions Weekly 1/2010 Zur Ausgabe

Case report

Ziprasidone